2024-04-27T12:00:00
Who does use KELIM in the world ?
Almost everyone ! The CA-125 KELIM is calculated > 2000 times every month in the world in > 50% of countries on the globe ! 50% on the neo-adjuvant engine et 50% on the adjuvant engine ...
2024-03-08T12:00:00
ESGO 2024: Oral presentation
Oral presentation at ESGO 2024: Benefit From Atezolizumab In Patients With A Poor Prognostic Ovarian Cancer In First-Line Setting: IMAGYN 050 Trial Benoit You et al. Session Date: 8 March 2024Session Time: 10:55-11:55
2024-03-07T12:00:00
ESGO 2024: KELIM discussion group
KELIM discussion meeting: Unformal discussion on March 7th 2024 in Room I (No. 119 - just opposite the session halls) between 10:30-12:00. We will discuss about the recent and future development of KELIM, including the future SALVOVAR trial.
2023-10-20T12:00:00
Meeting for SALVOVAR project at ESMO 2023
The partners, investigators and investigating groups of SALVOVAR project are invited to join for a face to face meeting at Madrid on October 20th 2023 at 12:00 am for partners and 2 pm for investigators Site: Novotel Madrid Campo de las Naciones (Hotel Novotel Madrid Campo de las Naciones) - Campo De Las Naciones, C. de Ámsterdam, N° 3, 28042 Madrid, Spain Just facing the convention center
2023-09-29T12:00:00
KELIM presented at ESGO 2023 !
Biomarker-Kinetics and KELIM were presented at ESGO 2023 in a session entitled "PARPi for the better or the worse ?"
2023-07-04T12:00:00
KELIM™ prognostic value in the GCIG meta-analysis dataset accepted in EJC
We are pleased to announce that the article about KELIM™ prognostic value in the GCIG meta-analysis dataset written by Pauline Corbaux was accepted for publication in the European Journal of Cancer !
2023-06-23T10:42:09
CA-125 KELIM™ was presented at the June 2023 MITO group (Napoli, Italy)
The Italian MITO group, celebrating the 25 years old anniversary of the fundation by Pr Sandro Pignata, invited Pr Benoit You to present the latest results of KELIM™ in patients with ovarian cancer. The session was entitled "Time to incorporate KELIM™ in our algorithms ?"
2023-06-21T20:00:00
A webcast about KELIM for the Belgian oncologists
GSK Belgium team invited Pr Benoit You to present the CA-125 KELIM™ lastest outcomes during the webcast chaired by Dr Christine Gennigens for Belgian oncologists. During an hour, the oncologists could ask many questions, and discuss how they could integrate KELIM™ in their decision-making algorithms